Introduction
The study of signalling elements in Mycobacterium tuberculosis (Mtb) has been a very active working area during the last 15 years, since the predicted presence, from the seminal publication of the complete sequence of M. tuberculosis H37Rv genome in 1998 [1] , of 11 'eukaryotic-like' Ser/Thr protein kinases (ePKs) in this pathogen. Despite huge efforts to identify their substrates and other interacting partners, leading to a large number of reported enzyme/substrate couples and to exploit some of these kinases as pharmacological targets, still little is known about the signalling pathways concerned, although an increasing bunch of evidence suggests the involvement of kinases in the control of cell division and infection (recently reviewed in Refs [2, 3] ). However, only two out of 11 ePKs coded by Mtb, i.e. PknA and PknB, have been proven to be essential for the bacterial survival [4] [5] [6] [7] , thus, raising more general questions about the physiological roles of the ensemble of ePKs, especially in the course of infection, about interactions with other players in signalling like the two-component systems and their possible functional redundancy. Initially among the less studied mycobacterial ePKs, partly due to the nonessentiality of the corresponding gene in vitro [8] , PknI (Rv2910c) has recently gained interest with the publication of a homology model [9] , the identification of two possible interaction partners [10] and the description of the phenotype of a double pknI
À knockout in Mtb [11] , confirming initial reports suggesting a role of PknI in infection [8] . In order to structurally characterize and compare PknI with other known ePKs, and eventually investigate the molecular basis of its role in the course of Mtb infection, we solved the crystal structure of the PknI catalytic domain. Here we describe how the structure of PknI, albeit showing most of the conserved elements characteristic of Hanks-type kinases, is not descriptive of an active ePK.
Results

Crystal structure of PknI kinase domain
For a structural characterization, recombinant PknI_1-256 (hereafter PknI) expressed and purified from Escherichia coli was subjected to crystallization trials and diffraction-quality crystals grew in the presence of ADP. The final atomic model obtained by Xray crystallography was refined at 2.0 A resolution (Table 1 ) and contains two copies of PknI within the asymmetric unit, encompassing residues 1-254 (plus an additional N-terminal histidine residue from the His 6 -tag) and 2-255, respectively (Fig. 1A,B) . Additionally, mFo-DFc r A -weighted electron density maps disclosed intense peaks in the substrate binding cleft of PknI monomer B, where it was possible to refine one ADP molecule and a Ca(II) cation, both present in the crystallization solution (Fig. 1C) . The representation of the electrostatic surface potential shows a predominant distribution of negative charges at the crevice between the two lobes, suggesting a role for the divalent ion as a charge neutralizer to allow nucleoside phosphate binding [12] (Fig. 1D) .
As shown in Fig. 1A , PknI presents the fold typically found in the family of ePKs. It comprises two lobes, i.e. the smaller N-lobe, that includes antiparallel b-strands and the prominent helix aC (Fig. 1C) , and the bigger C-lobe that is mostly a-helical. The two protein chains present in the asymmetric unit are very similar, with an RMSD value of 0. 24 A among 244 Ca, irrespective of the presence/absence of an ADP molecule within the active site. Unexpectedly, the PknI monomers in the asymmetric unit are linked by a disulfide bridge involving the same residue Cys20 from each monomer (Fig. 1B) , part of the conserved 'Glyrich loop' (or P-loop) on the tip of the b1-b2 turn (Fig. 1B,E) .
To determine whether the observed interaction between PknI monomers might be relevant in the physiological scenario or if it could constitute an artefact induced by the crystal lattice, we first used analytical ultracentrifugation to investigate the protein species in solution. The distribution of sedimentation coefficients clearly revealed two protein populations, consistent with a PknI monomer (s 0 20;w = 2.8 S) and a PknI dimer (s 0 20;w = 3.9 S) present in solution. The theoretical sedimentation coefficients calculated for one PknI monomer and the PknI dimer, as found in the crystallographic model, were 2.8 S and 4.4 S, respectively, showing agreement with the experimental data for the monomeric species only. We therefore decided to replace residue Cys20 by either serine or alanine, as found in the protein orthologues from other Mycobacterium species (Fig. 1E) , and to solve the crystal structure of PknI_C20S and PknI_C20A. While it was not possible to crystallize PknI_C20S, PknI_C20A crystals, nonisomorphous with respect to crystals of wild-type PknI, readily grew in the presence of high concentrations of NaCl. Crystals of apo PknI_C20A also contained two protein chains in the asymmetric unit, but packing interactions were different from those found in crystals of wild-type PknI and no covalent bonds were observed between monomers. Even though the crystallization assay did not include an added nucleotide, a residual, uninterpretable positive electron density in the mFo-DFc r A -weighted map occupied an area corresponding to the nucleotide pocket of monomer A (Fig. 2) , suggesting the presence of either an unidentified ligand or, alternatively, the N-terminal portion of the peptide chain from a neighbouring molecule. Nevertheless, the low RMSD values obtained after superimposing the two protein chains (0.76 A among 246 Ca) as well as when superimposing wild-type PknI and PknI_C20A chains (RMSD of 
0.55
A over 244 Ca), indicate that residue Cys20 and the disulfide bridge leading to dimerization have no significant impact on the overall conformation of the kinase domain (Fig. 3A) . Consistently, wild-type PknI and both mutants showed virtually identical circular dichroism spectra in the far and near UV (Fig. 3B) . Additionally, analytical ultracentrifugation analysis revealed that both PknI_C20A and PknI_C20S behaved as monomers in solution, with no significant amounts of high order species, even at high protein concentrations. Overall, although these results do not allow to rule out a physiological role for the disulfidelinked dimer observed in the crystal structure of wildtype PknI, this notion is especially challenged by the nonconservation of Cys20 among orthologous PknIs from different Mycobacterium species (Fig. 1E ).
The substrate binding cleft of PknI
Displaying the prototypical kinase fold and sequence motifs characteristic of Hanks-type kinases, as already noticed [10, 13] , the crystal structure of PknI presents some striking features. The activation segment, defined as the stretch running from the DFG to the APE conserved motifs [14] , lacks in PknI an activation loop and a P + 1 loop and is stabilized within the active site in a 'inward' conformation, incompatible with binding of peptide substrates (Figs 4A,B and 5A). Further, the salt bridge between the catalytic residue Lys41 and Glu60 in helix aC, one of the hallmarks of an ePK active state [15] , is hindered in PknI by the side chain of Ile162 in the activation segment (Fig. 4A) , similarly to the Src-like autoinhibited conformation observed in another M. tuberculosis Ser/Thr kinase, PknA [16] . Thus, the side chains of residues Lys41 and Glu60 are ca. 14 A apart, and Glu60 is found oriented towards the C-lobe, engaged in a salt bridge with residue Arg136 from the HRD motif (Fig. 4A) . Also, the amide N of residue Gly161 is not hydrogen bonded by the c-oxygen in Asp159 side chain, leading the DFG motif to adopt a configuration that has been associated with kinase off states [17] . This conformation is stabilized by residue Arg78 in strand b4, bridging the backbone carbonyl of Phe160 to Phe57 and Thr61 in a kink in helix aC (Fig. 4A, right panel) . In line with these observations, the catalytic and regulatory spines [18] are not properly assembled (Fig. 5B) . Overall, our structural data are not descriptive of an active protein kinase [14] .
The nucleotide-binding site of PknI
The adenine moiety of ADP bound to chain B in wildtype PknI structure is buried in a hydrophobic pocket and makes three direct hydrogen bonds with the enzyme: the amine N at position 6 binds the backbone carbonyl oxygen of Asp90, and the N 1 atom binds both the amide and the carbonyl of Val92 (Fig. 6A, left  panel) . Besides, van der Waals contacts are established with the side chains of Leu18, Val26, Ala39, Leu73, Met89 and Tyr91. The a-phosphate of ADP is bound by the side chain of Lys41, which also interacts with the carboxylate of Asp159 in the DFG motif, whereas the b-phosphate is bound by residue Asp96 (Fig. 6A , right panel), a position usually found interacting with the ribose moiety in the nucleotide instead [19, 20] . Interestingly, the conserved basic residue in the catalytic loop of ePKs (Lys168 in the archetypal kinase PKA), critical for keeping the ATP c-phosphate and the peptide substrate in the near-attack reactive configuration [21, 22] , is substituted by asparagine (Asn139) in PknI (Fig. 6A, right  panel) . Additionally, one calcium ion is coordinated by Asn142 in the catalytic loop, Asp159 in the DFG motif and one water molecule that also contacts both ADP phosphates. Notably, this one cation binding mode is the most common nucleotide binding mode found among pseudokinases structures, first seen in human epidermal growth factor family pseudokinase HER3 (PDB: 4RIW) [23] . Further, the Gly-rich loop of PknI, which in contrast to most ePKs contains a non-Gly residue in position 21, does not establish hydrogen bonds with the phosphates of ADP, found displaced out of the active site (Fig. 6B, left panel) . Finally, Met23 in the Gly-rich loop is involved in a network of hydrophobic interactions comprising residues from several structural motifs, most with key roles in catalysis by ePKs: residues Lys41 and Leu43 in strand b3, Met47 in helix aB, Phe53 and Phe57 in helix aC, Ile87 in strand b5, Asp159 in the DFG motif and Ile162 in the activation segment (Fig. 6B, right panel) .
The kinase domain of PknI has no detectable kinase activity
PknI presents a degraded Gly-rich loop, the activation loop and the P + 1 loop are missing from the activation segment, and ADP was found to adopt a binding mode commonly found in eukaryotic pseudokinases. Therefore, to explore PknI ability as a protein kinase, we employed wild-type PknI and Cys20 point mutants to perform kinase assays using different putative substrates (Fig. 7) . No autophosphorylation activity was detected in either case in assays containing as much as 25 lM PknI and 10 mM MnCl 2 or MgCl 2 . Besides, we failed to detect phosphorylation of the mycobacterial protein GarA or a 17-mer peptide derived from the N-terminus of GarA and containing the phosphorylatable ETTS motif (Fig. 7) [19] .
Active ePKs require a functional activation segment in an open conformation permissive for substrate binding. This led us to inquire whether modifications in the activation segment, either in its conformation or its nature, may provide PknI with detectable protein kinase activity. As the salt bridge observed between residues Glu60 and Arg136 may be important in stabilizing an inhibitory conformation of PknI activation segment (Fig. 4A) , we first substituted Arg136 with either alanine or asparagine, as found in the only known mycobacterial non-RD kinase PknG [19] . The crystal structure of mutants PknI_C20A_R136A and PknI_C20A_R136N revealed the activation segment in the same conformation observed for the wild-type kinase domain (Fig. 8) , whereas substitution of residue Arg136 did not provide PknI with detectable kinase activity (Fig. 7) . These results showed that neither Arg136 nor the salt bridge Glu60-Arg136 are required for stabilizing the observed conformation of the activation segment or the helix aC of PknI. Second, we replaced the segment 162-165 (IASQ) in PknI by the stretch FAKRVKGRTWDLCGT, a mimic of the phosphorylated activation segment of the archetypal human kinase PKA. Even though this motif has been found to adopt an open conformation allowing substrate binding in the ePK PKA [20] , the resulting mutant PknI_C20A_AS-PKA did not show detectable kinase activity (Fig. 7) .
Discussion
One of the key features that account for the success of Mtb as a human pathogen is its capability to adapt the physiological processes in response to different environments. Protein kinases provide a platform for the integration of signal transduction networks and structural analyses have greatly facilitated our knowledge about the molecular mechanisms underlying activity and regulation of these enzymes. Here, we present a structural, biophysical and biochemical characterization of protein kinase I from Mtb.
The overall fold of PknI kinase domain is very similar to that of known ePKs and shows the characteristic bilobal topology with a nucleotide-binding cleft between the two lobes (Fig. 1) . Already predicted by homology modelling [9] , the ensemble of our crystal structures shows that several structural motifs known to be critical for the activity of ePKs are severely degraded in PknI. Strikingly, the activation segment of PknI comprises only eight residues, whereas the same segment contains more than 20 amino acids in the closest mycobacterial orthologues PknA and PknB, and lacks the P + 1 loop essential for substrate binding (Figs 4 and 5A) . Indeed, the kinase domain of RNase L, similar to PknI in that it also contains an eight-residue activation segment, is devoid of kinase activity [24] . Besides, comparable to the eukaryotic pseudokinase ILK [25] , the activation segment of PknI is well ordered without any phosphorylation, and is stabilized by extensive interactions with the N-lobe in a conformation incompatible with substrate binding (Figs 4A and 5A) . Further, the DFG motif of PknI appears to be locked regardless of the presence of a bound nucleotide, a structural feature that is consistent with the rigidity of the activation loop. The wellconserved glycine-rich GXGXXG motif in ePKs is replaced by the GXSXXG motif in PknI that, in our crystal structure, does not form hydrogen bonds with ADP within the nucleotide binding site (Fig. 6B) . Notably, ADP binds to PknI by the one cation binding mode commonly found in eukaryotic pseudokinases (Fig. 6A ) [23] , and would place the ATP c-phosphate far away from the catalytic loop ( Figs 1C  and 6B) . Moreover, the catalytic loop of PknI includes residue Asn139 that corresponds to the catalytic lysine Lys168 in PKA (Fig. 6A) , critical for phosphotransfer [21, 22] . Overall, the deviations observed in the catalytic core show PknI adopting a conformational state that is also incompatible with catalysis as a conventional kinase.
Activation segment
Our attempts to detect kinase activity by the PknI kinase domain, either in autophosphorylation assays or using surrogate substrates like the protein GarA or a 17-mer GarA-derived peptide, were unsuccessful (Fig. 7) , similar to previous reports [2, 26] . In contrast, different groups reported autophosphorylation and phosphorylation of myelin basic protein (MBP) and GarA by recombinant, full-length PknI purified from the soluble fraction of E. coli [13, 26, 27] . Therefore, yet unknown regulation mechanisms possibly to ascribe to the interactions of PknI, embedded in the cell membrane, with other signalling partners cannot be excluded. Besides, known activation mechanisms for mycobacterial kinases, like dimerization, cannot be discarded either. However, even though PknI can form dimers via an intermolecular disulfide bridge involving residue Cys20 (Fig. 1B) , the fact that this position is not conserved among PknI from different species (Fig. 1E) argues against a conserved role for the observed interaction. On the other hand, mutants PknI_C20A and PknI_C20S behaved as monomers in solution, with no evidence of stable back-to-back dimers as previously found for the mycobacterial kinases PknB [28] , PknD [29] and PknE [30] . Thus, the apparently unconventional molecular mechanism mediating PknI kinase activity, reported to be as low as 10
at 21 degrees against MBP [27] , remains to be elucidated, although mechanisms other than its catalytic activity, like, for instance, a role as a signalling scaffold or regulator, might have to be taken into account to explain the physiological role of PknI.
Materials and methods
Chemicals
The synthetic 17-mer peptide SDEVTVETTSVFRADFL, corresponding to residues 14-30 of the protein GarA, was purchased from Thermo Fisher Scientific (Ulm, Germany) with a purity > 98%.
Cloning and mutagenesis
Plasmid pET28a-PknI for the expression of the kinase catalytic domain with a hexahistidine tag was constructed by PCR amplification of pknI codons 1-336, coding for the whole intracellular region of PknI, from Mycobacterium tuberculosis H37Rv genomic DNA, cloning into the NdeI and HindIII sites in plasmid pET28a (Novagen, Darmstadt, Germany), then site-directed mutagenesis to replace the codon coding Val257 with a stop codon. Likewise, plasmids pET28a-PknI_C20A and pET28a-PknI_C20S were generated by site-directed mutagenesis. Plasmids pET28a-PknI_C20A_R136A, pET28a-PknI_C20A_R136N and pET28a-PknI_C20A_AS-PKA were provided by GenScript (Piscataway, NJ, USA) using plasmid pET28a-PknI_C20A as template.
Protein production and purification
Wild-type PknI and mutants were over-produced in E. coli BL21(DE3) cells. Proteins were expressed for 18-20 h at 22°C with 500 lM IPTG and then purified following the same protocol. E. coli cells were harvested by centrifugation, resuspended in lysis buffer (50 mM NaH 2 PO 4 , 500 mM NaCl, 5% glycerol, 25 mM imidazole, pH 8.0) supplemented with complete protease inhibitor cocktail (Roche, Meylan, France) and sonicated. After clarification by centrifugation, the supernatant was loaded onto a HisTrap HP column (GE Healthcare, Velizy-Villacoublay, France) and the His 6 -tagged protein was recovered applying a linear imidazole gradient (25-400 mM). The protein was then further purified by size-exclusion chromatography on a Superdex 75 column (GE Healthcare) equilibrated in 25 mM Hepes-NaOH, 150 mM NaCl, 5% glycerol, pH 8.0. Fractions corresponding to PknI, as confirmed by SDS/PAGE, were pooled and concentrated, flash-frozen in liquid nitrogen and stored at À80°C. GarA was prepared as previously described [31] . Proteins were quantified using the molar absorption coefficient predicted from the aminoacid sequence by the ProtParam tool (http://web.expasy.org/protparam/). ) and were performed at room temperature. Reactions were stopped after 1.5 h by the addition of phosphoric acid and 4 lL of each reaction were spotted on P81 phosphocellulose papers (Whatman). Papers were washed in 0.01% phosphoric acid, dried, then measured and analysed using a Phosphorimager apparatus (Storm TM ; GE Healthcare). Each reaction was performed in duplicates and each assay was performed twice.
Protein kinase activity assay
Analytical ultracentrifugation
Sedimentation velocity experiments were carried out at 20°C in an XL-I analytical ultracentrifuge (Beckman Coulter, Villepinte, France). Samples were spun using an An60Ti rotor and 12-mm double sector epoxy centrepieces. The partial specific volume of PknI (0.729 mLÁg À1 ) was estimated from their amino acid sequences using the software Sednterp. The same software was used to estimate the buffer viscosity (g = 1.036 centipoises) and density (q = 1.007 gÁmL À1 ).
PknI (400 lL at 10, 20 and 35 lM) was spun at 42 000 rpm, and absorbance profiles were recorded every 5 min. Sedimentation coefficient distributions, c(s), were determined using the software SEDFIT 15.01b [32] . Theoretical hydrodynamic radii and sedimentation coefficients of PknI (wild-type and mutants) were calculated from the atomic coordinates using Winhydropro [33] with a hydrated radius of 2.84 A for the atomic elements.
Circular dichroism
Measurements were performed using a CD 215 spectropolarimeter (Aviv) flushed with N 2 . Protein samples were dialysed against a buffer containing 25 mM Hepes-Na pH 8.0, 150 mM NaCl, 5% glycerol, 1 mM DTT and diluted to 1 mgÁmL À1 . Scans were performed in the range 195-260 nm (Far-UV) and 250-320 nm (Near-UV) using a cylindrical 0.2 mm cell (Suprasil) and a 1 nmÁs À1 scan rate.
Crystallization and data collection
Crystallization screenings were carried out using the sittingdrop vapour diffusion method and a Mosquito nanolitre-dispensing crystallization robot (TTP Labtech, Melbourn, UK and PknI_C20A_R136N crystals grew within 1 week, using 100 mM Hepes-Na, NaCl 4.3 M, pH 7.5 as a mother liquor, at 18°C. In each case, single crystals were cryprotected in mother liquor supplemented with either 25% methanol (PknI) or 25% glycerol (PknI_C20A_R136A, PknI_-C20A_R136N), and flash-frozen in liquid nitrogen. In the case of PknI_C20A crystals, the cryoprotectant solution was 4.6 M NaCl, 0.1 M Hepes-Na, pH 8.5.
Data collection, structure determination and refinement X-ray diffraction data were collected at 100 K at the beamlines Proxima 1 (Synchrotron Soleil, Saint-Aubin, France) and ID29 (ESRF, Grenoble, France). The diffraction data were processed using XDS [34] and scaled with Aimless or Scala from the CCP4 program suite [35] . The crystal structure of PknI was solved by multiwavelength anomalous diffraction (MAD) on a 2.9 A resolution data set from a SeMet-labelled crystal, collected at Proxima 1 ( Table 1) . Thirteen selenium sites were located with the program SHELXD [36] processing only the Se K-edge peak dataset; subsequent MAD phasing and density modification by solvent flattening were carried out with autoSHARP [37] . A preliminary model was obtained by placing the C-terminal domain of M. tuberculosis PknB [38] (PDB: 1O6Y) in the resulting solvent flattened electron density map with Molrep [39] ; the model was then extended through manual tracing with COOT [40] , alternated with refinement with refmac5 [41] and further tracing in the resulting Fourier difference maps, and eventually used as the search model for molecular replacement on a native dataset ( Table 1 ). The structures of PknI_C20A, PknI_C20A_R136A and PknI_C20A_R136N were then solved using the refined atomic coordinates of wild-type PknI (Table 1) . Ligand molecules were manually placed in mFo-DFc r A -weighted electron density maps employing COOT [40] . Structures were refined through iterative cycles of manual model building with COOT [40] and reciprocal space refinement with BUSTER (Global Phasing Ltd., Cambridge, UK), applying noncrystallographic symmetry restraints [42] and validated through the Molprobity server (http://molprobity.biochem.duke.edu) [43] . Figures were generated and rendered with PYMOL 1.5.0.2. (Schr€ odinger, LLC, Cambridge, MA, USA). Atomic coordinates and structure factors have been deposited in the Protein Data Bank under the accession codes 5M06 (wild-type PknI + ADP), 5M07 (PknI_C20A), 5M08 (PknI_C20A_ R136A) and 5M09 (PknI_C20A_R136N).
